Single Heterocyclic Compounds as Monoamine Oxidase Inhibitors: From Past to Present
2020 ◽
Vol 20
(10)
◽
pp. 908-920
◽
Keyword(s):
The Past
◽
Inhibitors of monoamine oxidase (MAO) have shown therapeutic values in a variety of neurodegenerative diseases such as depression, Parkinson’s disease and Alzheimer’s disease. Heterocyclic compounds exhibit a broad spectrum of biological activities and vital leading compounds for the development of chemical drugs. Herein, we focus on the synthesis and screening of novel single heterocyclic derivatives with MAO inhibitory activities during the past decade. This review covers recent pharmacological advancements of single heterocyclic moiety along with structure- activity relationship to provide better correlation among different structures and their receptor interactions.
2016 ◽
Vol 5
(5)
◽
pp. 568-588
2019 ◽
Vol 16
(3)
◽
pp. 333-340
1995 ◽
Vol 38
(19)
◽
pp. 3874-3883
◽
2019 ◽
Vol 19
(10)
◽
pp. 809-825
◽
2019 ◽
Vol 110
◽
pp. 118-128
◽